HNI Corp. (HNI) Tops Q3 EPS by 6c, Offers Q4 Guidance

HNI Corp. (NYSE: HNI) reported Q3 EPS of $0.93, $0.06 better than the analyst estimate of $0.87. Revenue for the quarter came in at $615.9 million versus the consensus estimate of $661.95 million.

HNI Corp. sees Q4 2015 EPS of $2.55-$2.60, versus the consensus of $2.58. The Corporation estimates sales to be down 4 to 8 percent in the fourth quarter over the same period in the prior year

For earnings history and earnings-related data on HNI Corp. (HNI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c